CRISPR-Cas9: a prominent genome editing tool in the management of inherited blood disorders and hematological malignancies
Year: 2025
Type: review
Institution: Mashhad University of Medical Sciences
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: CRISPR/Cas9, genome editing, inherited blood disorders, sickle cell disease, beta-thalassemia, Fanconi anemia, hematologic malignancies, allogeneic hematopoietic stem cell transplantation, ex vivo gene therapy, autologous hematopoietic stem cells, chimeric antigen receptor T cells, off-target effects, immunogenicity
Open Access status: closed
OpenAlex ID: W4412678122
